Filing Details
- Accession Number:
- 0001127602-13-013314
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-04-03 16:58:16
- Reporting Period:
- 2013-04-01
- Filing Date:
- 2013-04-03
- Accepted Time:
- 2013-04-03 16:58:16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1320940 | B William Hayes | 531 South Spring Street Burlington NC 27215 | Chief Financial Officer, Evp | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-04-01 | 4,949 | $89.96 | 23,574 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.
- The price of $89.955 per share represents a weighted average of sales prices ranging from $89.69 to $90.338 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.